Quantcast
Last updated on April 21, 2014 at 12:39 EDT

Latest Conatus Stories

2012-07-12 06:24:59

SAN DIEGO, July 12, 2012 /PRNewswire/ -- Conatus Pharmaceuticals Inc. announced today the appointment of Mark F. Morris as Head of Biostatistics effective immediately. In this newly created position, Mr. Morris will oversee the statistical design of the company's human clinical trials. "Mark provides an enormous amount of technical expertise in statistical design and analysis," said Steven J. Mento, Ph.D., President and CEO. "His broad experience in drug development including the hepatology...

2011-10-25 13:00:00

SAN DIEGO, Oct. 25, 2011 /PRNewswire/ -- Conatus Pharmaceuticals Inc. announced today the termination of its Phase 2 clinical trial of CTS-1027 in HCV patients. This decision follows reports of laboratory abnormalities and adverse events in a subset of clinical trial participants. The top priority of Conatus is patient safety, and the Company has made the decision to halt this study. Conatus is conducting a thorough review of the available data to assess any future development of the...

2011-02-11 13:00:00

SAN DIEGO, Feb. 11, 2011 /PRNewswire/ -- Conatus Pharmaceuticals Inc. today announced the closing of a $20 million Series B Preferred Stock private placement financing. This financing was led by new investor, AgeChem Venture Fund of Montreal, Canada, and included participation by existing investors; Aberdare Ventures, Advent Venture Partners, Bay City Capital, Gilde Healthcare Partners, and Roche Venture Fund. Conatus will use the proceeds to advance the clinical development of CTS-1027,...

2010-07-30 11:04:00

SAN DIEGO, July 30 /PRNewswire/ -- Conatus Pharmaceuticals Inc. announced today that Conatus acquired the Idun Pharmaceuticals subsidiary of Pfizer Inc. Financial terms were not disclosed. Conatus Pharmaceuticals is a privately-held drug development company focused on liver disease and oncology. Conatus Pharmaceuticals is led by Steven J. Mento, Ph.D., the former CEO of Idun Pharmaceuticals, which was acquired by Pfizer Inc. in 2005. "The addition of Idun to Conatus continues our...